TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy

Eva Nievergall, John Reynolds, Chung Hoow Kok, Dale B. Watkins, Mark Biondo, Samantha J. Busfield, G Vairo, Kathryn A. Fuller, Wendy N. Erber, Teresa Sadras,

Leukemia · 2016 · 50 citations · 46 references

Concepts

References

46